147
Compass Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
195
FY23:
154
FY24:
133
FY25:
210
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.65
FY22:
4.85
FY23:
2.99
FY24:
7.65
FY25:
9.77
Total assets
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
200
FY23:
157
FY24:
140
FY25:
220
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.6
FY22:
16.2
FY23:
7.80
FY24:
8.87
FY25:
14.0
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.05
FY22:
1.84
FY23:
0.54
FY24:
6.30
FY25:
8.83
(positive)
Change from FY21 to FY25
millions USD
FY21:
140
FY22:
182
FY23:
149
FY24:
125
FY25:
197
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
154
FY22:
200
FY23:
157
FY24:
140
FY25:
220
All amounts in millions USD